Non-Invasive Screening Tools for Down's Syndrome: A Review

Diagnostics
Kelly A SillenceNeil D Avent

Abstract

Down's syndrome (DS) is the most common genetic cause of developmental delay with an incidence of 1 in 800 live births, and is the predominant reason why women choose to undergo invasive prenatal diagnosis. However, as invasive tests are associated with around a 1% risk of miscarriage new non-invasive tests have been long sought after. Recently, the most promising approach for non-invasive prenatal diagnosis (NIPD) has been provided by the introduction of next generation sequencing (NGS) technologies. The clinical application of NIPD for DS detection is not yet applicable, as large scale validation studies in low-risk pregnancies need to be completed. Currently, prenatal screening is still the first line test for the detection of fetal aneuploidy. Screening cannot diagnose DS, but developing a more advanced screening program can help to improve detection rates, and therefore reduce the number of women offered invasive tests. This article describes how the prenatal screening program has developed since the introduction of maternal age as the original "screening" test, and subsequently discusses recent advances in detecting new screening markers with reference to both proteomic and bioinformatic techniques.

References

Sep 6, 1992·The New England Journal of Medicine·J E HaddowG B Bowers
Aug 6, 1987·The New England Journal of Medicine·M S DiMaioM J Mahoney
Nov 26, 1987·The New England Journal of Medicine·B R BenacerrafF D Frigoletto
Apr 1, 1984·American Journal of Obstetrics and Gynecology·I R MerkatzW E Johnson
May 1, 1995·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·P P PandyaK H Nicolaides
Sep 1, 1994·British Journal of Obstetrics and Gynaecology·K H NicolaidesR J Snijders
May 9, 1996·The New England Journal of Medicine·D A AitkenJ M Connor
Dec 1, 1996·Clinical Obstetrics and Gynecology·L M Hill
Aug 16, 1997·Lancet·Y M LoJ S Wainscoat
Mar 24, 1998·Prenatal Diagnosis·L S Chitty, P P Pandya
Dec 10, 1998·The New England Journal of Medicine·Y M LoJ S Wainscoat
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·B Vogelstein, K W Kinzler
Nov 7, 1999·Seminars in Perinatology·J A Canick, L H Kellner
Mar 7, 2001·JAMA : the Journal of the American Medical Association·R Smith-BindmanJ D Goldberg
Jun 13, 2001·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·D A Nyberg, V L Souter
Apr 12, 2002·Journal of Medical Screening·J K MorrisE Alberman
May 1, 2002·Prenatal Diagnosis·Thomas D Shipp, Beryl R Benacerraf
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Malcolm A Ferguson-Smith
Sep 13, 2003·Reproduction : the Official Journal of the Society for the Study of Fertility·Maj A HulténBarbara Pertl
Oct 7, 2004·American Journal of Obstetrics and Gynecology·James F X EganAdam F Borgida
Mar 1, 2005·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·K H NicolaidesO Falcon
Oct 4, 2005·Obstetrics and Gynecology·Diana W BianchiC Ellen van der Schoot
Oct 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Stephen S C ChimY M Dennis Lo
Mar 30, 2006·Journal of Medical Screening·N J Wald
Jul 28, 2006·Down's Syndrome, Research and Practice : the Journal of the Sarah Duffen Centre·Elizabeth Crane, Joan K Morris
Oct 13, 2006·American Journal of Medical Genetics. Part a·Cheryl L MaslenStephanie L Sherman
Feb 10, 2007·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Lisa G Shaffer, The-Hung Bui
Mar 10, 2007·American Journal of Obstetrics and Gynecology·Yrtti ValinenMarkku Ryynanen
May 16, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·A M JaquesL J Sheffield
Aug 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·Y M Dennis LoRossa W K Chiu
Oct 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·H Christina FanStephen R Quake
Nov 13, 2008·Prenatal Diagnosis·Bernhard G ZimmermannSinuhe Hahn
Nov 26, 2008·Down's Syndrome, Research and Practice : the Journal of the Sarah Duffen Centre·Frank Buckley, Sue Buckley
Jan 28, 2009·Reproductive Biology and Endocrinology : RB&E·Laurence A Cole

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
PCR
chips
chip

Software Mentioned

FORTE
MPSS
DANSR Optimized Risk of Trisomy Evaluation ( FORTE )
Ion Torrent
Digital Analysis of Selected DANSR
HiSeq2000

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC
Rebecca SparkesPhil Wyatt
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
Julia Grinshpun-CohenElon Pras
© 2021 Meta ULC. All rights reserved